Entera Bio Stock Investor Sentiment
| ENTX Stock | USD 2.05 0.01 0.49% |
Slightly above 70 percent of all Entera Bio's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Entera Bio suggests that a large number of traders are confidant. Entera Bio's investing sentiment can be driven by a variety of factors including economic data, Entera Bio's earnings reports, geopolitical events, and overall market trends.
Comfort Level 70
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Entera Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Entera Bio.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentAcquiring |
Entera Historical Sentiment
Although Entera Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Entera, such as negative comments on social media and news outlets, may cause fear in the market and push Entera Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Entera.
Entera Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Entera Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Entera Bio Historical Investor Sentiment
Investor biases related to Entera Bio's public news can be used to forecast risks associated with an investment in Entera. The trend in average sentiment can be used to explain how an investor holding Entera can time the market purely based on public headlines and social activities around Entera Bio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Entera Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Entera Bio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Entera Bio news discussions. The higher the estimate score, the more favorable the investor's outlook on Entera Bio.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Entera Bio's Stock prices. Below is the latest headlines and news related to Entera Bio Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Entera Bio that are available to investors today. This information is accessible both publicly - through Entera Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Entera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Entera Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Entera Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Entera Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Entera Bio alpha.
Entera Largest EPS Surprises
Earnings surprises can significantly impact Entera Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-08 | 2025-03-31 | -0.07 | -0.0607 | 0.0093 | 13 | ||
2024-05-10 | 2024-03-31 | -0.06 | -0.05 | 0.01 | 16 | ||
2024-03-08 | 2023-12-31 | -0.08 | -0.07 | 0.01 | 12 | ||
2025-03-06 | 2024-12-31 | -0.08 | -0.06 | 0.02 | 25 | ||
2023-11-14 | 2023-09-30 | -0.09 | -0.07 | 0.02 | 22 | ||
2022-11-10 | 2022-09-30 | -0.13 | -0.11 | 0.02 | 15 |
There is far too much social signal, news, headlines, and media speculation about Entera Bio that are available to investors today. This information is accessible both publicly - through Entera Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Entera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Entera Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Entera Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Entera Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Entera Bio alpha.
Entera Bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Galitzer Hillel of 26316 shares of Entera Bio subject to Rule 16b-3 | 04/28/2025 |
2 | Insider Trading | 05/08/2025 |
3 | Disposition of 150000 shares by Gregory Burshtein of Entera Bio at 1.99 subject to Rule 16b-3 | 05/12/2025 |
4 | Entera Bio Registers 100 Million Mixed Securities Shelf Offering ENTX Stock News | 05/30/2025 |
5 | OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1Glucagon Tablet Candidate for ... | 06/25/2025 |
6 | Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual... | 06/26/2025 |
7 | OPKO Health to Present OPK-88006 Data at ENDO 2025 - MSN | 07/03/2025 |
8 | OPKO Health and Entera Bio Announce Abstract on PKPD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress | 07/08/2025 |
9 | Acquisition by Yaacov-garbeli Dana of 26316 shares of Entera Bio subject to Rule 16b-3 | 07/16/2025 |
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.